US Stock MarketDetailed Quotes

CGEM Cullinan Therapeutics

Watchlist
  • 12.700
  • -0.100-0.78%
Trading Dec 4 09:30 ET
739.49MMarket Cap-4471P/E (TTM)

Cullinan Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
9.04%48.86M
33.03%50.03M
-31.50%42.99M
44.28%190.65M
39.49%45.49M
50.52%44.8M
1.34%37.61M
92.17%62.76M
52.06%132.14M
-5.06%32.61M
Selling and administrative expenses
21.55%13.35M
34.80%13.77M
15.79%12.34M
5.73%42.49M
-5.76%10.64M
8.88%10.98M
-4.50%10.21M
31.26%10.66M
37.89%40.19M
-16.20%11.29M
-General and administrative expense
21.55%13.35M
34.80%13.77M
15.79%12.34M
5.73%42.49M
-5.76%10.64M
8.88%10.98M
-4.50%10.21M
31.26%10.66M
37.89%40.19M
-16.20%11.29M
Research and development costs
4.98%35.51M
32.38%36.26M
-41.17%30.65M
61.13%148.16M
63.44%34.85M
71.85%33.82M
3.71%27.39M
112.32%52.1M
59.21%91.95M
2.12%21.32M
Operating profit
-9.04%-48.86M
-33.03%-50.03M
31.50%-42.99M
-44.28%-190.65M
-39.49%-45.49M
-50.52%-44.8M
-1.34%-37.61M
-92.17%-62.76M
-94.45%-132.14M
5.06%-32.61M
Net non-operating interest income expense
42.59%8.38M
51.65%8.07M
26.29%5.69M
227.14%21.63M
75.89%5.92M
149.89%5.88M
663.56%5.32M
2,188.32%4.51M
1,285.95%6.61M
2,355.47%3.36M
Non-operating interest income
42.59%8.38M
51.65%8.07M
26.29%5.69M
227.14%21.63M
75.89%5.92M
149.89%5.88M
663.56%5.32M
2,188.32%4.51M
1,285.95%6.61M
2,355.47%3.36M
Other net income (expense)
65.77%-89K
-204.35%-72K
-141.12%-44K
-100.07%-201K
-139.26%-117K
-260K
-99.98%69K
107K
3,460,625.00%276.84M
7,350.00%298K
Special income (charges)
--0
----
----
-100.16%-440K
--0
---440K
----
----
--276.79M
--0
-Less:Impairment of capital assets
--0
----
----
--440K
--0
--440K
----
----
--0
--0
-Gain on sale of business
----
----
----
--0
----
----
----
----
--276.79M
--0
Other non- operating income (expenses)
-149.44%-89K
-204.35%-72K
-141.12%-44K
319.30%239K
-139.26%-117K
--180K
128.63%69K
--107K
812.50%57K
7,350.00%298K
Income before tax
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
-211.83%-169.22M
-37.10%-39.69M
-42.94%-39.18M
-113.41%-32.21M
-79.12%-58.14M
324.22%151.32M
15.38%-28.95M
Income tax
-133.53%-14.12M
42.12M
-1.86M
Net income
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
-242.04%-155.1M
5.63%-25.56M
-57.42%-39.18M
-118.51%-32.21M
-350.99%-58.14M
261.81%109.2M
20.81%-27.09M
Net income continuous Operations
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
-242.04%-155.1M
5.63%-25.56M
-57.42%-39.18M
-118.51%-32.21M
-350.99%-58.14M
261.81%109.2M
20.81%-27.09M
Minority interest income
0
0
-7.26%-192K
3.96%-1.94M
-475.16%-1.76M
0
0
77.46%-179K
-5.43%-2.02M
81.91%-306K
Net income attributable to the parent company
-3.51%-40.56M
-30.47%-42.03M
35.91%-37.15M
-237.72%-153.16M
11.12%-23.8M
-57.97%-39.18M
-118.42%-32.21M
-379.10%-57.96M
269.61%111.21M
17.63%-26.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-3.51%-40.56M
-30.47%-42.03M
35.91%-37.15M
-237.72%-153.16M
11.12%-23.8M
-57.97%-39.18M
-118.42%-32.21M
-379.10%-57.96M
269.61%111.21M
17.63%-26.78M
Basic earnings per share
24.18%-0.69
8.54%-0.75
39.44%-0.86
-250.00%-3.69
8.47%-0.54
-68.52%-0.91
-121.03%-0.82
-425.93%-1.42
261.84%2.46
20.27%-0.59
Diluted earnings per share
24.18%-0.69
8.54%-0.75
39.44%-0.86
-255.04%-3.69
8.47%-0.54
-68.52%-0.91
-121.75%-0.82
-425.93%-1.42
256.58%2.38
20.27%-0.59
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 9.04%48.86M33.03%50.03M-31.50%42.99M44.28%190.65M39.49%45.49M50.52%44.8M1.34%37.61M92.17%62.76M52.06%132.14M-5.06%32.61M
Selling and administrative expenses 21.55%13.35M34.80%13.77M15.79%12.34M5.73%42.49M-5.76%10.64M8.88%10.98M-4.50%10.21M31.26%10.66M37.89%40.19M-16.20%11.29M
-General and administrative expense 21.55%13.35M34.80%13.77M15.79%12.34M5.73%42.49M-5.76%10.64M8.88%10.98M-4.50%10.21M31.26%10.66M37.89%40.19M-16.20%11.29M
Research and development costs 4.98%35.51M32.38%36.26M-41.17%30.65M61.13%148.16M63.44%34.85M71.85%33.82M3.71%27.39M112.32%52.1M59.21%91.95M2.12%21.32M
Operating profit -9.04%-48.86M-33.03%-50.03M31.50%-42.99M-44.28%-190.65M-39.49%-45.49M-50.52%-44.8M-1.34%-37.61M-92.17%-62.76M-94.45%-132.14M5.06%-32.61M
Net non-operating interest income expense 42.59%8.38M51.65%8.07M26.29%5.69M227.14%21.63M75.89%5.92M149.89%5.88M663.56%5.32M2,188.32%4.51M1,285.95%6.61M2,355.47%3.36M
Non-operating interest income 42.59%8.38M51.65%8.07M26.29%5.69M227.14%21.63M75.89%5.92M149.89%5.88M663.56%5.32M2,188.32%4.51M1,285.95%6.61M2,355.47%3.36M
Other net income (expense) 65.77%-89K-204.35%-72K-141.12%-44K-100.07%-201K-139.26%-117K-260K-99.98%69K107K3,460,625.00%276.84M7,350.00%298K
Special income (charges) --0---------100.16%-440K--0---440K----------276.79M--0
-Less:Impairment of capital assets --0----------440K--0--440K----------0--0
-Gain on sale of business --------------0------------------276.79M--0
Other non- operating income (expenses) -149.44%-89K-204.35%-72K-141.12%-44K319.30%239K-139.26%-117K--180K128.63%69K--107K812.50%57K7,350.00%298K
Income before tax -3.51%-40.56M-30.47%-42.03M35.78%-37.34M-211.83%-169.22M-37.10%-39.69M-42.94%-39.18M-113.41%-32.21M-79.12%-58.14M324.22%151.32M15.38%-28.95M
Income tax -133.53%-14.12M42.12M-1.86M
Net income -3.51%-40.56M-30.47%-42.03M35.78%-37.34M-242.04%-155.1M5.63%-25.56M-57.42%-39.18M-118.51%-32.21M-350.99%-58.14M261.81%109.2M20.81%-27.09M
Net income continuous Operations -3.51%-40.56M-30.47%-42.03M35.78%-37.34M-242.04%-155.1M5.63%-25.56M-57.42%-39.18M-118.51%-32.21M-350.99%-58.14M261.81%109.2M20.81%-27.09M
Minority interest income 00-7.26%-192K3.96%-1.94M-475.16%-1.76M0077.46%-179K-5.43%-2.02M81.91%-306K
Net income attributable to the parent company -3.51%-40.56M-30.47%-42.03M35.91%-37.15M-237.72%-153.16M11.12%-23.8M-57.97%-39.18M-118.42%-32.21M-379.10%-57.96M269.61%111.21M17.63%-26.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -3.51%-40.56M-30.47%-42.03M35.91%-37.15M-237.72%-153.16M11.12%-23.8M-57.97%-39.18M-118.42%-32.21M-379.10%-57.96M269.61%111.21M17.63%-26.78M
Basic earnings per share 24.18%-0.698.54%-0.7539.44%-0.86-250.00%-3.698.47%-0.54-68.52%-0.91-121.03%-0.82-425.93%-1.42261.84%2.4620.27%-0.59
Diluted earnings per share 24.18%-0.698.54%-0.7539.44%-0.86-255.04%-3.698.47%-0.54-68.52%-0.91-121.75%-0.82-425.93%-1.42256.58%2.3820.27%-0.59
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Symbol Mini Chart % Chg
Abits
ABTS
-1.48%
SATO TECHNOLOGIES CORP
CCPUF
0.00%
CATHEDRA BITCOIN INC
CBTTF
0.00%
Bitdeer Technologies
BTDR
+1.42%
Intchains Group
ICG
0.00%

Unlock the Full List